e-learning
resources
Virtual 2020
Monday, 07.09.2020
New and integrated tools for respiratory diagnosis and care
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
A new statistical diagnostic tool for respiratory diseases
M. Wiegand (Cambridge/ Manchester, United Kingdom), S. Nadarajah (Manchester, United Kingdom), J. Smith (Manchester, United Kingdom), K. Holt (Manchester, United Kingdom), K. Mcguinness (Manchester, United Kingdom)
Source:
Virtual Congress 2020 – New and integrated tools for respiratory diagnosis and care
Session:
New and integrated tools for respiratory diagnosis and care
Session type:
Oral Presentation
Number:
3819
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Wiegand (Cambridge/ Manchester, United Kingdom), S. Nadarajah (Manchester, United Kingdom), J. Smith (Manchester, United Kingdom), K. Holt (Manchester, United Kingdom), K. Mcguinness (Manchester, United Kingdom). A new statistical diagnostic tool for respiratory diseases. 3819
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
A 12-year-old male child with fever, productive cough and sudden onset paralysis
A 41-year-old male with cough productive of yellow sputum and worsening breathlessness
Related content which might interest you:
Non-targeted integrative multi-omics approaches on sputum reveal potential diagnostic and monitoring biomarkers for respiratory diseases
Source: International Congress 2017 – Novel molecular and genetic targets in COPD
Year: 2017
A web-based diagnostic tool for chronic cough within the community
Source: Eur Respir J 2006; 28: Suppl. 50, 437s
Year: 2006
Fine crackles quantitative value can help the diagnosis of interstitial lung diseases – Clinical utility of the innovative analyzing system of respiratory sounds
Source: International Congress 2019 – Innovations in primary care assessment and management
Year: 2019
Biomarker-guided design to test clinical proof of concept in allergic respiratory diseases of UR-63325, a new H
4
R antagonist
Source: Annual Congress 2010 - New treatments for asthma and COPD
Year: 2010
New uses of data: from big data to artificial intelligence and clinical decision tools in children with respiratory diseases
Source: Virtual Congress 2021 – New technologies for the management of children with respiratory diseases
Year: 2021
From the bedside: upcoming new clinical strategies: novel strategies to combat respiratory viral infections
Source: International Congress 2017 – Scientific year in review
Year: 2017
Applying clinical metagenomics for the detection and characterisation of respiratory infections
Source: Eur Respir Monogr 2019; 83: 35-49
Year: 2019
Diagnostic performance of routine objective tests and cost-effective approach for chronic cough
Source: Eur Respir J 2004; 24: Suppl. 48, 537s
Year: 2004
Application of text analytics for identification of respiratory diseases in medical claims
Source: Virtual Congress 2020 – Digital health interventions in respiratory medicine
Year: 2020
Novel diagnostic tools and interventions for COPD locomotor and respiratory muscle dysfunction
Source: International Congress 2017 – PG18 Targeting the locomotor and respiratory muscles in chronic obstructive pulmonary disease: novel interventional tools and rehabilitation strategies
Year: 2017
Advances in diagnostic tools for lower respiratory tract infections
Source: Virtual Congress 2021 – Community-acquired pneumonia: the new perspective in the post-COVID era
Year: 2021
Are FENO indices useful diagnostic tools in suspected asthma? Experience of a routine lung function laboratory
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011
Phospholipids qualitative analysis: A new diagnostic tool to characterize
ABCA3
-Associated disease and guide genetic analysis
Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Year: 2010
A combinational approach to optimize biomarkers efficacy in identifying patients with sarcoidosis and monitoring respiratory functional worsening
Source: Annual Congress 2012 - Diffuse parenchymal lung disease IV
Year: 2012
Exercise on how to include the new rapid methods into diagnostic algorithms
Source: Annual Congress 2012 - PG7 TB and MDR-/XDR-TB: what is new in diagnosis, treatment and follow-up (TB PAN-NET)
Year: 2012
Development of a diagnostic decision tree for obstructive pulmonary diseases based on real-life data
Source: ERJ Open Res 2016
Year: 2016
Is an informative application a suitable tool for patients in a diagnostic lung cancer program?A qualitative study
Source: Virtual Congress 2021 – Innovations in nurse-led interventions in respiratory diseases
Year: 2021
Hypoventilation during sleep: risk factors, diagnostic algorithms and therapeutic approaches
Source: International Congress 2019 – PG17 Sleep apnoea and hypoventilation: obstruction and more
Year: 2019
Recognition of the respiratory pathology by statistic methods
Source: Eur Respir J 2001; 18: Suppl. 33, 240s
Year: 2001
Clinical exercise testing with reference to lung diseases: indications, standardization and interpretation strategies
Source: Guideline 1997
Year: 1997
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept